Clinical Trial Update: Postinfectious Irritable Bowel Syndrome and Gelsectan [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for postinfectious irritable bowel syndrome evaluating Gelsectan; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Gelsectan

Snippet

Sponsor: Evangelismos Hospital | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED